See if serum BDNF levels relate to outcomes in chronic low back pain
Official title: The Prediction of Clinical Outcome Using the Serum BDNF Level
Run by Keimyung University Dongsan Medical Center · NCT07776379 · Data updated 2026-11-12
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 80 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Keimyung University Dongsan Medical Center Academic / other |
| Locations | 1 site (Daegu, Daegu) |
| Status | Recruiting |
| Started | August 13, 2026 |
| Main results expected | March 30, 2028 |
| Study ends | May 30, 2028 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07776379 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with chronic low back pain due to disc degeneration or spinal stenosis, with MRI evidence, and no excluded comorbidities, may be eligible.
✕Probably not a fit
Patients with secondary back pain, recent spine surgery, inflammatory or neuromuscular conditions, or medications affecting BDNF may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study explores whether serum Brain-Derived Neurotrophic Factor (BDNF) levels are linked to clinical outcomes in adults with chronic low back pain due to disc degeneration or spinal stenosis. Blood samples will be collected for ELISA analysis alongside standard assessments, and participants may receive an erector spinae plane block as part of the protocol. The study relies on MRI-confirmed disc pathology and excludes patients with conditions or medications known to affect BDNF. By correlating BDNF with pain, function, and other outcomes, the trial aims to identify potential markers for prognosis or stratification. The investigation is conducted at Keimyung University Dongsan Medical Center in Daegu, Korea.
Why it matters
Potential benefit: If correlations are found, BDNF could become a biomarker to help predict who might respond best to certain treatments.
How similar studies have gone: Some prior work has explored BDNF as a biomarker in musculoskeletal pain, but this study addresses a relatively novel link in chronic low back pain.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Chronic low back pain patients with or without leg pain due to disc degeneration or spinal stenosis * Patients who have MRI Exclusion Criteria: * Secondary low back pain (spine fracture, infection, tumor) * recent history of spine surgery * systemic inflammatory disease (rheumatoid arthritis, SLE, ankylosing spondylitis) * peripheral neuropathy or central nervous system injury * fibromyalgia * drugs which can affect the serum BDNF level (anti depressant, anti parkinsonian drug, acetylcholinesterase inhibitor, anti psychotics)
Where it's running
-
Ji Hee
Daegu, Daegu, South Korea Recruiting
Study contacts
- Study coordinator: JIHEE Hong
- Email: swon13@daum.net
- Phone: 01046794343
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
-
Algorithm-informed care to find the best pain treatment for chronic low back pain
This study tests whether an algorithm that uses a patient’s symptoms, history, and lifestyle can help pick the best treatment from physical therapy, duloxetine, acupressure, or PRISM-CBT for people with chronic low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.